Several pathological observations have documented TB reactivation following PD-L1 blockade even in the absence of corticosteroid or other immunosuppressive exposure, suggesting a distinct immunopathological basis for this phenomenon (Liu et al., 2022). The gene discussed is CD274; the disease is tuberculosis.